Introduction:
At HaemoGene, we are dedicated to enhancing patient care in the field of haematology and oncology. Through strategic partnerships and our extensive network, we aim to provide patients with access to cutting-edge treatments and research opportunities, ultimately improving their outcomes.

Clinical Trials Services:

– Facilitated Access to Clinical Trials: Utilising our diverse network and strong affiliations with major drug affiliates, HaemoGene offers facilitated access to a wide range of clinical trials in haematology and oncology. Our partnerships enable us to gain trusted access to clinical trial opportunities, ensuring patients have access to the latest treatments and advancements in the field.
– Consultancy Services: Our team provides expert consultancy services to healthcare professionals regarding the latest clinical trials and treatment options available for haematology and oncology patients. We stay updated on emerging therapies and advancements, ensuring that healthcare professionals and patients are informed and empowered to make the best treatment decisions.
– Patient Enrollment Assistance: HaemoGene assists in patient enrollment in clinical trials by coordinating with healthcare providers and research teams. We streamline the enrollment process, ensuring that eligible patients have the opportunity to participate in clinical trials and access potentially life-saving treatments.
– Compliance and Advocacy: We collaborate closely with regulatory authorities and ethics committees to ensure compliance with regulatory requirements and ethical standards in clinical trial conduct. Additionally, HaemoGene advocates for the inclusion of haematology and oncology patients in clinical trials, expanding treatment options and improving outcomes for patients.
– Leveraging Strategic Partnerships: Through our affiliations with Health Service Laboratories (HSL), University College London (UCL), and The Doctors Laboratory (TDL) groups, HaemoGene has established a robust networking pathway. This allows us to seamlessly collaborate and access cutting-edge research opportunities, particularly through UCL’s leadership in clinical trials.